Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

被引:4
作者
Olejarz, Wioletta [1 ,2 ]
Sadowski, Karol [1 ,2 ,3 ]
Szulczyk, Daniel [4 ]
Basak, Grzegorz [3 ]
机构
[1] Med Univ Warsaw, Fac Pharm, Dept Biochem & Pharmacogen, PL-02097 Warsaw, Poland
[2] Med Univ Warsaw, Ctr Preclin Res, PL-02097 Warsaw, Poland
[3] Med Univ Warsaw, Dept Hematol Transplantat & Internal Med, PL-02097 Warsaw, Poland
[4] Med Univ Warsaw, Chair & Dept Biochem, PL-02097 Warsaw, Poland
关键词
CAR-T; EVs; immunotherapy; biomarkers; hematological malignancies; checkpoint inhibitors; TME; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; EPSTEIN-BARR-VIRUS; CELL-FREE DNA; CIRCULATING TUMOR DNA; NON-HODGKIN-LYMPHOMA; INHIBITORY RECEPTORS; IMMUNE MICROENVIRONMENT; GENE REARRANGEMENTS; MULTIPLE-MYELOMA;
D O I
10.3390/ijms25147743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chimeric antigen receptor T-cell (CAR-T) therapy is a novel anticancer therapy using autologous or allogeneic T-cells. To date, six CAR-T therapies for specific B-cell acute lymphoblastic leukemia (B-ALL), non-Hodgkin lymphomas (NHL), and multiple myeloma (MM) have been approved by the Food and Drug Administration (FDA). Significant barriers to the effectiveness of CAR-T therapy include cytokine release syndrome (CRS), neurotoxicity in the case of Allogeneic Stem Cell Transplantation (Allo-SCT) graft-versus-host-disease (GVHD), antigen escape, modest antitumor activity, restricted trafficking, limited persistence, the immunosuppressive microenvironment, and senescence and exhaustion of CAR-Ts. Furthermore, cancer drug resistance remains a major problem in clinical practice. CAR-T therapy, in combination with checkpoint blockades and bispecific T-cell engagers (BiTEs) or other drugs, appears to be an appealing anticancer strategy. Many of these agents have shown impressive results, combining efficacy with tolerability. Biomarkers like extracellular vesicles (EVs), cell-free DNA (cfDNA), circulating tumor (ctDNA) and miRNAs may play an important role in toxicity, relapse assessment, and efficacy prediction, and can be implicated in clinical applications of CAR-T therapy and in establishing safe and efficacious personalized medicine. However, further research is required to fully comprehend the particular side effects of immunomodulation, to ascertain the best order and combination of this medication with conventional chemotherapy and targeted therapies, and to find reliable predictive biomarkers.
引用
收藏
页数:23
相关论文
共 235 条
  • [11] CAR T therapy beyond cancer: the evolution of a living drug
    Baker, Daniel J.
    Arany, Zoltan
    Baur, Joseph A.
    Epstein, Jonathan A.
    June, Carl H.
    [J]. NATURE, 2023, 619 (7971) : 707 - 715
  • [12] Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia
    Barrett, David M.
    Liu, Xiaojun
    Jiang, Shuguang
    June, Carl H.
    Grupp, Stephan A.
    Zhao, Yangbing
    [J]. HUMAN GENE THERAPY, 2013, 24 (08) : 717 - 727
  • [13] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [14] Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients
    Bastion, Y
    Sebban, C
    Berger, F
    Felman, P
    Salles, G
    Dumontet, C
    Bryon, PA
    Coiffier, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1587 - 1594
  • [15] Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
    Bastos-Oreiro, Mariana
    Sanz-Villanueva, Laura
    Muniz, Paula
    Bailen, Rebeca
    Chicano, Maria
    Oarbeskoa, Gillen
    Gomez, Isabel
    Gutierrez, Antonio
    de la Iglesia, Ismael
    Carbonell, Diego
    Diaz-Crespo, Francisco Javier
    Menarguez, Javier
    Diez-Martin, Jose Luis
    Kwon, Mi
    Buno, Ismael
    Martinez-Laperche, Carolina
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 472e1 - 472e4
  • [16] Identification of a Conserved Glycan Signature for Microvesicles
    Batista, Bianca S.
    Eng, William S.
    Pilobello, Kanoelani T.
    Hendricks-Munoz, Karen D.
    Mahal, Lara K.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2011, 10 (10) : 4624 - 4633
  • [17] Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
    Beaver, Julia A.
    Jelovac, Danijela
    Balukrishna, Sasidharan
    Cochran, Rory L.
    Croessmann, Sarah
    Zabransky, Daniel J.
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cidado, Justin
    Blair, Brian G.
    Chu, David
    Burns, Timothy
    Higgins, Michaela J.
    Stearns, Vered
    Jacobs, Lisa
    Habibi, Mehran
    Lange, Julie
    Hurley, Paula J.
    Lauring, Josh
    VanDenBerg, Dustin A.
    Kessler, Jill
    Jeter, Stacie
    Samuels, Michael L.
    Maar, Dianna
    Cope, Leslie
    Cimino-Mathews, Ashley
    Argani, Pedram
    Wolff, Antonio C.
    Park, Ben Ho
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (10) : 2643 - 2650
  • [18] Ciltacabtagene autoleucel, a B-cell maturation antigendirected chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
    Berdeja, Jesus G.
    Madduri, Deepu
    Usmani, Saad Z.
    Jakubowiak, Andrzej
    Agha, Mounzer
    Cohen, Adam D.
    Stewart, A. Keith
    Hari, Parameswaran
    Htut, Myo
    Lesokhin, Alexander
    Deol, Abhinav
    Munshi, Nikhil C.
    O'Donnell, Elizabeth
    Avigan, David
    Singh, Indrajeet
    Zudaire, Enrique
    Yeh, Tzu-Min
    Allred, Alicia J.
    Olyslager, Yunsi
    Banerjee, Arnob
    Jackson, Carolyn C.
    Goldberg, Jenna D.
    Schecter, Jordan M.
    Deraedt, William
    Zhuang, Sen Hong
    Infante, Jeffrey
    Geng, Dong
    Wu, Xiaoling
    Carrasco-Alfonso, Marlene J.
    Akram, Muhammad
    Hossain, Farah
    Rizvi, Syed
    Fan, Frank
    Lin, Yi
    Martin, Thomas
    Jagannath, Sundar
    [J]. LANCET, 2021, 398 (10297) : 314 - 324
  • [19] DNA Sequencing versus Standard Prenatal Aneuploidy Screening
    Bianchi, Diana W.
    Parker, R. Lamar
    Wentworth, Jeffrey
    Madankumar, Rajeevi
    Saffer, Craig
    Das, Anita F.
    Craig, Joseph A.
    Chudova, Darya I.
    Devers, Patricia L.
    Jones, Keith W.
    Oliver, Kelly
    Rava, Richard P.
    Sehnert, Amy J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09) : 799 - 808
  • [20] Acute Lymphoblastic Leukemia in Early Childhood as the Presenting Sign of Ataxia-Telangiectasia Variant
    Bielorai, Bella
    Fisher, Tamar
    Waldman, Dalia
    Lerenthal, Yaniv
    Nissenkorn, Andreea
    Tohami, Tali
    Marek, Dina
    Amariglio, Ninette
    Toren, Amos
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (06) : 574 - 582